GNS Healthcare Inc. (Cambridge, Mass.) said it has identified four genes as “top drivers” of high-risk multiple myeloma. Using its machine learning technology, the company is collaborating with the Multiple Myeloma Research Foundation (MMRF) to analyze data in the foundation’s patient-driven, real-world CoMMpass study.
Read the full story here.